Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

News

New study enables identification of people at particular risk of rare, but serious, muscle-related side effect of statin therapy

About 5000 heart attack sufferers in England missed out on lifesaving hospital treatment due to the COVID-19 pandemic

£10 million for cancer epidemiology studies

Red meat and fish consumption in China associated with risk of diabetes

New heart disease drug to be made available to NHS patients through ground-breaking collaboration

Combined vitamin D and calcium supplements reduce fracture risk

Why we need large prospective studies in different populations

Disappointing results in trial of minocycline in people with mild Alzheimer's disease

NDPH scientists join prestigious Academy of Medical Sciences Fellowship

CDC Foundation, Amgen announce programme to support studies of cardiovascular diseases globally

Professor Sarah Darby elected a Fellow of the Royal Society

Moderate alcohol consumption does not protect against stroke

High cholesterol strongly linked to risk of stroke

Do null results on cognitive function in cardiovascular trials exclude worthwhile benefit?

Increasing dose intensity of chemotherapy reduces the risk of breast cancer recurrence and death

Statin therapy reduces cardiovascular disease risk in older people

Hypertension and cardiovascular mortality in Cuba

Professor Jane Armitage recognised for services to medical research

Convincing evidence that type 2 diabetes is a cause of erectile dysfunction

Statin safety

Load More